Although the diagnostic performance for detecting CRC (sensitivity >60%; specificity >80%) of the three individual markers SPAG9, RPH3AL, and CCDC83 was inferior to that for FIT, the panel of the autoantibodies had higher sensitivity for detecting AA than FIT. This evidence concerns the gene RPH3AL and colorectal carcinoma.